Deer Park, IL, and Dubai, UAE – September 28, 2026 – Airway Innovations, Inc., a medical device company dedicated to improving the safety, efficiency, and cost-effectiveness of deep IV sedation, TIVA, and post-extubation airway management, today announced an exclusive distribution agreement with AYDAMED Medical Surgical Equipment Trading L.L.C. ("AYDAMED") for the AERIS Airway® in the United Arab Emirates. The agreement marks the first introduction of the AERIS Airway in the Middle East.

AYDAMED is a specialized medical equipment supplier in the UAE that selectively sources advanced medical technologies from global innovators to meet the demands of a rapidly evolving healthcare landscape. The company's mission extends beyond bringing products to market: AYDAMED builds long-term partnerships with manufacturers and healthcare professionals to support the adoption of technologies that contribute to safer, smarter, and more efficient clinical practice.

Under the agreement, AYDAMED will market, sell, and support the AERIS Airway, an innovative device that converts standard adult Guedel oropharyngeal airways (OPAs) and adult nasopharyngeal airways (NPAs) into advanced supraglottic oxygenation and capnography systems. By delivering a high fraction of inspired oxygen (FiO₂) at low oxygen flow rates and enabling continuous end-tidal CO₂ monitoring, the AERIS Airway is designed to reduce the risk of hypoxemia, streamline the anesthesia workflow, and facilitate lower overall surgical and procedural costs. AYDAMED will engage clinicians across Anesthesia, Critical Care, Emergency Medicine, and Respiratory Care to establish a strong foundation for the device's introduction across the region.

"The UAE is home to some of the most forward-looking healthcare systems in the world, and AYDAMED shares our belief that patient safety during sedation should not depend on complex or costly technology," said Paul Fehrenbacher, Chief Executive Officer of Airway Innovations. "AYDAMED's focus on partnering closely with clinicians, rather than simply placing products, makes them the right partner to introduce the AERIS Airway to anesthesia and critical care teams in the Emirates and to build the foundation for our growth across the Middle East."

The AERIS Airway fits into standard adult Guedel OPAs and adult NPAs, allowing anesthesia providers to incorporate the device into their current workflow with minimal change. The device delivers FiO₂ up to 80% at oxygen flows as low as 2–4 L/min and up to 100% at 6–10 L/min, while capturing real-time, high-fidelity capnography waveforms to support ventilatory decision-making. The AERIS Airway can be used whenever an adult Guedel OPA or NPA is used, including during deep IV sedation, TIVA, post-extubation, and in emergency medical settings. The AERIS Airway also exceeds the ASA guidelines for monitoring EtCO₂ during IV sedation and TIVA.

"As the first company to introduce AERIS to the Middle East, AYDAMED is proud to contribute to the advancement of airway management, oxygen delivery, and respiratory monitoring in the region," said Mina Mounir, CEO of AYDAMED. "Our vision is to bring next-generation medical technologies closer to the healthcare professionals who need them. The AERIS Airway is a simple, single-use solution that improves oxygenation and CO₂ monitoring without asking providers to change how they work, and we look forward to working with leading clinicians across the UAE to support its adoption."

Healthcare providers in the UAE interested in evaluating the AERIS Airway can contact AYDAMED or reach Airway Innovations directly for more information and to schedule a demonstration.

About Airway Innovations, Inc.

Airway Innovations is an Illinois-based medical device company focused on creating intuitive, evidence-based airway management solutions that improve patient safety, simplify provider workflow, and reduce the cost of care. The company's flagship product, the AERIS Airway®, is designed to modernize IV anesthesia, post-extubation care, and emergency medical services by combining efficient supraglottic oxygen delivery with continuous capnography in a simple, single-use device. For more information, visit airwayinnovations.com or contact info@airwayinnovations.com.

About AYDAMED Medical Surgical Equipment Trading L.L.C.

AYDAMED is a specialized medical equipment supplier based in the United Arab Emirates. The company selectively sources advanced medical technologies from global innovators and partners with healthcare professionals to support the adoption of solutions that contribute to safer, smarter, and more efficient clinical practice across the UAE and the wider Middle East. For more information, visit https://www.linkedin.com/company/aydamed or email mina@aydamed.ae.

Airway Innovations Contact:
Paul A. Fehrenbacher, CEO
paul.fehrenbacher@airwayinnovations.com
312.624.8787

AYDAMED Contact:
Mina Mounir, CEO
mina@aydamed.ae
+971 54 780 3166